JW Pharmaceutical Corp Total Liabilities

Latest as of June 2026: ₩249.96 Billion KRW ≈ $169.39 Million USD

JW Pharmaceutical Corp total liabilities. Based on the latest financial reports, JW Pharmaceutical Corp (001065) has total liabilities worth ₩249.96 Billion KRW (≈ $169.39 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check JW Pharmaceutical Corp liquidity resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of JW Pharmaceutical Corp (2014–2025)

Total liabilities of JW Pharmaceutical Corp from 2014 to 2025. This chart illustrates how JW Pharmaceutical Corp's total liabilities have evolved over time, based on quarterly financial data. Explore JW Pharmaceutical Corp strategic investment ratio to see how much of total assets are deployed in long-term investments.

JW Pharmaceutical Corp Competitors by Total Liabilities

The table below lists competitors of JW Pharmaceutical Corp ranked by their total liabilities.

Company Country Total Liabilities
J.Jill Inc
NYSE:JILL
USA $313.18 Million
Laser Tek Taiwan Co Ltd
TWO:6207
Taiwan NT$2.17 Billion
Accent Group Ltd
AU:AX1
Australia AU$850.23 Million
Jiangsu Yuxing Film Tech
SHE:300305
China CN¥1.30 Billion
Ratnaveer Precision Engineering Ltd
NSE:RATNAVEER
India Rs5.10 Billion
Eastern Pioneer Auto Driving S
SHG:603377
China CN¥2.98 Billion
Wuhan Hanshang Group Co Ltd
SHG:600774
China CN¥1.65 Billion
Cotec Construction JSC
VN:CTD
Vietnam ₫29.10 Trillion

Liability Composition Analysis (2014–2025)

This chart breaks down JW Pharmaceutical Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 001065 current and non-current assets.

Liquidity & Leverage Metrics

JW Pharmaceutical Corp Total Liabilities Ratios Explained

JW Pharmaceutical Corp total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.56 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.61 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.38 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how JW Pharmaceutical Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for JW Pharmaceutical Corp (2014–2025)

The table below shows the annual total liabilities of JW Pharmaceutical Corp from 2014 to 2025.

Year Total Liabilities Change
2025-12-31 ₩235.90 Billion
≈ $159.87 Million
-14.25%
2024-12-31 ₩275.11 Billion
≈ $186.44 Million
-27.53%
2023-12-31 ₩379.60 Billion
≈ $257.25 Million
-5.62%
2022-12-31 ₩402.21 Billion
≈ $272.57 Million
-9.52%
2021-12-31 ₩444.51 Billion
≈ $301.24 Million
+30.12%
2020-12-31 ₩341.62 Billion
≈ $231.51 Million
-0.44%
2019-12-31 ₩343.12 Billion
≈ $232.52 Million
+2.83%
2018-12-31 ₩333.68 Billion
≈ $226.13 Million
-7.34%
2017-12-31 ₩360.10 Billion
≈ $244.03 Million
-3.91%
2016-12-31 ₩374.76 Billion
≈ $253.97 Million
-3.43%
2015-12-31 ₩388.07 Billion
≈ $262.99 Million
+5.11%
2014-12-31 ₩369.22 Billion
≈ $250.21 Million
--

About JW Pharmaceutical Corp

KO:001065 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$278.50 Million
₩410.96 Billion KRW
Market Cap Rank
#14890 Global
#477 in Korea
Share Price
₩20450.00
Change (1 day)
-2.15%
52-Week Range
₩19800.00 - ₩29850.00
All Time High
₩88605.96
About

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam steri… Read more